Skip to main content
. 2018 Sep 10;20(9):e259. doi: 10.2196/jmir.9966

Table 3.

Median scores and significance test results for self-reported variables among groups.

Characteristics Stage 1a (agree)a (n=23), n (%) Stage 1b+ (agree)b (n=26), n (%) Stage 1b+ (disagree)c (n=19), n (%) Significance test Hd or FETe (P) Post hoc P values
a vs c b vs c
Demographics

Female, n (%) 15 (65) 18 (69) 14 (74) 1.70e (.72) f

Age in years, median (IQR)g 20.00 (4) 20.50 (4) 21.00 (4) 0.78d (.86)

Education 1.58e (.71)


Secondary, n (%) 12 (52) 14 (54) 8 (42)


Tertiary, n (%) 11 (48) 12 (46) 11 (58)
Clinical characteristics

K-10h, median (IQR) 25 (13) 32.0 (9) 28.0 (13) 5.51d (.14)

Depression/anxiety (current), n (%) 16 (70) 22 (85) 14 (74) 6.03e (.09)

Hypomanic-like issue (current), n (%) 5 (22) 10 (38) 6 (32) 2.91e (.38)

Psychotic-like issue (current), n (%) 5 (22) 12 (46) 7 (37) 4.92e (.15)

Mental health history, n (%) 11 (48) 20 (77) 18 (95) 11.83e (.005) .001 .21

Lifetime self-harm, n (%) 7 (30) 20 (77) 7 (37) 13.28e (.003) .67 .007
Suicidality

SIDASi, median (IQR) 1 (4) 9.5 (24) 1 (5) 12.59d (.006) .71 .008

Suicide planning history, n (%) 0 (0) 12 (46) 7 (37) 17.75e (<.001) .002 .53

Suicide attempt history, n (%) 0 (0) 6 (23) 1 (5) 6.98e (.04) .45 .21
Alcohol and/or other substance misuse

Lifetime substance misuse, n (%) 17 (74) 18 (69) 14 (74) 0.36e (.98)

Cannabis weekly, n (%) 1 (4) 8 (31) 6 (32) 7.60e (.04) .03 .95

Substances to cope with emotions, n (%) 6 (26) 18 (69) 8 (42) 10.85e (.009) .24 .07

aStage 1a by online and face-to-face clinicians.

bStage 1b+ by online and face-to-face clinicians.

cStage 1b+ by online clinicians but assessed as Stage 1a by face-to-face clinicians.

dKruskal–Wallis test, 2-tailed.

eFET: Fisher exact test, 2-tailed.

fNot applicable.

gIQR: Interquartile range.

hK-10: 10-item Kessler Psychological Distress Scale.

iSIDAS: Suicidal Ideation Attributes Scale.